Ali Oguz Er
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Oguz Er has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Bektur Abdisatarov
Superconducting Quantum Materials and Systems Center, Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
1 shared publication - Berdimyrat Annamuradov
Department of Physics and Astronomy, Western Kentucky University 3 , Bowling Green, Kentucky 42101
1 shared publication - Liviu Duta
National Institute for Laser, Plasma and Radiation Physics, 077125 Magurele, Romania
1 shared publication - Salizhan Kylychbekov
Department of Physics & Astronomy, Western Kentucky University, Bowling Green, KY 42101, USA
1 shared publication - Yaran Allamyradov
Department of Physics and Astronomy, Western Kentucky University 3 , Bowling Green, Kentucky 42101
1 shared publication
Latest Publications
- Open Access
- 11 February 2026
- Published by AIP Publishing in Journal of Applied Physics
- Vol. 139 (6)
The mechanism of hydroxyapatite coatings degradation at high substrate temperatures
Physical vapor deposition methods used for hydroxyapatite (HA) coatings typically require elevated substrate temperatures and post-deposition annealing to induce crystallization. However, such thermal treatments can degrade both the mechanical integrity and bioactivity of the coating, particularly when substrate temperatures exceed 500 °C. The mechanisms underlying these phenomena remain insufficiently understood. In this study, HA thin films were deposited on silicon and Ti6Al4V substrates using pulsed laser deposition and were systematically characterized to elucidate these mechanisms. XPS and SIMS analyses revealed a temperature-dependent loss of OH− and PO43− groups, an increased Ca/P ratio, and the formation of interfacial oxides, all of which contribute to weakened adhesion. To clarify the temperature-dependent decline in bioactivity, protein adsorption behavior was analyzed using a Kramers-type kinetic framework; the fitted desorption kinetics indicate that coatings deposited near ∼500 °C provide the most stable protein attachment, whereas higher temperatures accelerate desorption due to dehydroxylation and carbonate substitution. Together, these findings provide mechanistic insight into the thermal degradation of HA coatings and offer a framework for optimizing deposition parameters to preserve stoichiometry, adhesion, and bioactivity for long-term biomedical applications.
- 11 February 2026
- Published by AIP Publishing in Journal of Applied Physics
- Vol. 139 (6)
Open AccessThe mechanism of hydroxyapatite coatings degradation at high substrate temperatures
Physical vapor deposition methods used for hydroxyapatite (HA) coatings typically require elevated substrate temperatures and post-deposition annealing to induce crystallization. However, such thermal treatments can degrade both the mechanical integrity and bioactivity of the coating, particularly when substrate temperatures exceed 500 °C. The mechanisms underlying these phenomena remain insufficiently understood. In this study, HA thin films were deposited on silicon and Ti6Al4V substrates using pulsed laser deposition and were systematically characterized to elucidate these mechanisms. XPS and SIMS analyses revealed a temperature-dependent loss of OH− and PO43− groups, an increased Ca/P ratio, and the formation of interfacial oxides, all of which contribute to weakened adhesion. To clarify the temperature-dependent decline in bioactivity, protein adsorption behavior was analyzed using a Kramers-type kinetic framework; the fitted desorption kinetics indicate that coatings deposited near ∼500 °C provide the most stable protein attachment, whereas higher temperatures accelerate desorption due to dehydroxylation and carbonate substitution. Together, these findings provide mechanistic insight into the thermal degradation of HA coatings and offer a framework for optimizing deposition parameters to preserve stoichiometry, adhesion, and bioactivity for long-term biomedical applications.